Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotrastaurin-based immunosuppression versus tacrolimus control in de novo liver transplant recipients
2007-001776-36Phase 2Terminated
- Sponsor
- Novartis
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of sotrastaurin in liver transplant (3 arms), sponsored by Novartis. Primary endpoint: Primary efficacy failure at Month 6. Started Dec 2008; status: terminated.
02
Drugs
sotrastaurin
03
Conditions
liver transplant
Beyond the preview
Go deeper on 2007-001776-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001776-36.